Adaptive Biotechnologies (ADPT) Treasury Shares (2019 - 2026)

Adaptive Biotechnologies (ADPT) has 8 years of Treasury Shares data on file, last reported at $4.5 million in Q1 2026.

• Quarterly Treasury Shares fell 61.51% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 61.51% YoY) and the FY2025 annual result came in at $11.2 million, up 10.52% from the prior year.
• Treasury Shares retreated to $4.5 million in Q1 2026 per ADPT's latest filing, from $11.2 million in the prior quarter.
• The five-year high for Treasury Shares was $11.8 million in Q1 2025, with the low at $1.9 million in Q2 2024.
• Average Treasury Shares over 5 years is $7.3 million, with a median of $6.0 million recorded in 2022.
• Year-over-year, Treasury Shares surged 742.56% in 2022 and slumped 82.18% in 2024.
• Adaptive Biotechnologies' Treasury Shares stood at $6.0 million in 2022, then jumped by 61.65% to $9.7 million in 2023, then rose by 5.23% to $10.2 million in 2024, then advanced by 10.52% to $11.2 million in 2025, then tumbled by 59.61% to $4.5 million in 2026.
• Business Quant data shows ADPT's Treasury Shares at $4.5 million in Q1 2026, $11.2 million in Q4 2025, and $11.5 million in Q3 2025.